Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Comment

Eli Lilly’s mirikizumab continues to show positive results in Phase II study for Crohn’s disease

Close
Close
Close

Go Top